Skip to main content
American Journal of Physiology - Cell Physiology logoLink to American Journal of Physiology - Cell Physiology
. 2018 Jan 3;314(4):C504–C517. doi: 10.1152/ajpcell.00272.2017

Hypoxia selectively upregulates cation channels and increases cytosolic [Ca2+] in pulmonary, but not coronary, arterial smooth muscle cells

Xi He 1,2, Shanshan Song 2, Ramon J Ayon 2, Angela Balisterieri 2, Stephen M Black 2,3, Ayako Makino 2,3, W Gil Wier 3, Wei-Jin Zang 1, Jason X-J Yuan 2,3,✉
PMCID: PMC5966788  PMID: 29351410

Abstract

Ca2+ signaling, particularly the mechanism via store-operated Ca2+ entry (SOCE) and receptor-operated Ca2+ entry (ROCE), plays a critical role in the development of acute hypoxia-induced pulmonary vasoconstriction and chronic hypoxia-induced pulmonary hypertension. This study aimed to test the hypothesis that chronic hypoxia differentially regulates the expression of proteins that mediate SOCE and ROCE [stromal interacting molecule (STIM), Orai, and canonical transient receptor potential channel TRPC6] in pulmonary (PASMC) and coronary (CASMC) artery smooth muscle cells. The resting cytosolic [Ca2+] ([Ca2+]cyt) and the stored [Ca2+] in the sarcoplasmic reticulum were not different in CASMC and PASMC. Seahorse measurement showed a similar level of mitochondrial bioenergetics (basal respiration and ATP production) between CASMC and PASMC. Glycolysis was significantly higher in PASMC than in CASMC. The amplitudes of cyclopiazonic acid-induced SOCE and OAG-induced ROCE in CASMC are slightly, but significantly, greater than in PASMC. The frequency and the area under the curve of Ca2+ oscillations induced by ATP and histamine were also larger in CASMC than in PASMC. Na+/Ca2+ exchanger-mediated increases in [Ca2+]cyt did not differ significantly between CASMC and PASMC. The basal protein expression levels of STIM1/2, Orai1/2, and TRPC6 were higher in CASMC than in PASMC, but hypoxia (3% O2 for 72 h) significantly upregulated protein expression levels of STIM1/STIM2, Orai1/Orai2, and TRPC6 and increased the resting [Ca2+]cyt only in PASMC, but not in CASMC. The different response of essential components of store-operated and receptor-operated Ca2+ channels to hypoxia is a unique intrinsic property of PASMC, which is likely one of the important explanations why hypoxia causes pulmonary vasoconstriction and induces pulmonary vascular remodeling, but causes coronary vasodilation.

Keywords: calcium signaling, coronary vasodilation, hypoxia, hypoxic pulmonary vasoconstriction

INTRODUCTION

The pulmonary circulation is a high-flow, low-resistance and low-pressure circulatory system that differs functionally and structurally from the systemic circulation system, e.g., the coronary circulation system (30, 71). Blood in the pulmonary artery is the deoxygenated venous blood, while the blood in the coronary artery is the oxygenated (oxygen-rich) arterial blood. A unique aspect of the pulmonary circulation is the vasoconstrictor response to hypoxia, whereas systemic arteries undergo dilation (15, 56, 57). Hypoxic pulmonary vasoconstriction (HPV) serves as an essential physiological process to assure efficient gas exchange by optimizing ventilation-perfusion (V/Q) matching via diverting the blood from poorly ventilated regions to well-ventilated areas of the lung (17, 44, 61). Persistent and widespread hypoxia throughout the lung, as occurring in patients with chronic obstructive pulmonary disease and obstructive sleep apnea or in residents living at high altitude, results in hypoxic pulmonary hypertension (HPH) by inducing sustained pulmonary vasoconstriction and pulmonary vascular medial hypertrophy. HPH-associated increase in afterload would then result in right ventricular hypertrophy and right heart failure (44, 49, 61). In contrast, systemic blood vessels dilate in response to tissue hypoxia, and this response appears to be critical to enhance blood flow and oxygen supply to hypoxic or hypoxemic tissues. The cellular and molecular mechanisms underlying the diverse cellular responses in pulmonary and systemic (e.g., coronary) artery smooth muscle cells, however, are still not clearly understood despite the vast efforts of investigators to elucidate the mechanism.

Vasoconstriction and vasodilatation are regulated by changes in cytosolic Ca2+ concentration ([Ca2+]cyt) in vascular smooth muscle cells. An increase in [Ca2+]cyt in smooth muscle cells is a key factor in the initiation and maintenance of vascular contraction, and a decrease in [Ca2+]cyt due to Ca2+ extrusion or sequestration is required for vasodilation. Accumulating evidence suggests that an increase in [Ca2+]cyt in pulmonary artery smooth muscle cells (PASMC) is a crucial trigger for pulmonary vasoconstriction and an important stimulus for pulmonary vascular remodeling by stimulating PASMC proliferation and migration (47, 59, 65). In PASMC, [Ca2+]cyt is elevated by 1) Ca2+ influx through Ca2+ -permeable channels in the plasma membrane, 2) Ca2+ release from the intracellular stores (e.g., sarcoplasmic reticulum), and 3) inward Ca2+ transportation by plasmalemmal Na+/Ca2+ exchangers when intracellular Na+ concentration is raised (28, 33, 65, 67, 68). Based on the proposed models of activation, the Ca2+-permeable channels responsible for Ca2+ influx are classified into three categories: 1) voltage-dependent Ca2+ channels (VDCC), which are primarily opened by membrane depolarization; 2) store-operated Ca2+ channels (SOCC), which are activated by active and passive depletion of Ca2+ from the intracellular stores (e.g., the sarcoplasmic or endoplasmic reticulum); and 3) receptor-operated Ca2+ channels (ROCC), which are activated by ligand binding to membrane receptors (23, 43, 47).

The canonical transient receptor potential (TRPC) channels, such as TRPC6, are the major components of ROCC responsible for receptor-operated Ca2+ entry (ROCE) (29). Recent evidence suggests that stromal interacting molecule proteins (e.g., STIM1/2) and Orai1/2 channels are the major components of SOCC leading to store-operated Ca2+ entry (SOCE) (9–11). Some reports also indicate that TRPC channels contribute to forming SOCC and regulating SOCE (5, 35). That Ca2+ signaling plays a critical role in a wide range of cell functions underscores the importance of understanding the mechanisms involved in regulating Ca2+ homeostasis in pulmonary (PASMC) and systemic or coronary arterial smooth muscle cells (CASMC) under both physiologic and pathophysiologic conditions.

Accumulating evidence suggests that increased [Ca2+]cyt in PASMC is the major determinant contributing to pulmonary vasoconstriction induced by acute hypoxia and pulmonary vascular wall thickening (due to PASMC proliferation) induced by chronic hypoxia (28). Studies showed that the increase of [Ca2+]cyt in PASMC exposed to acute hypoxia was due to many mechanisms including 1) membrane depolarization-induced opening of VDCC, 2) active store depletion-induced SOCE through SOCC or STIM/Orai channels, and 3) agonist-mediated ROCE through ROCC or TRPC channels (51, 54). The elevated resting [Ca2+]cyt in PASMC and the pulmonary arterial tone of chronically hypoxic rats can be reduced to the control level by antagonists of nonselective cation channels and blockers of VDCC. Chronic hypoxia not only downregulates voltage-gated K+ channels, leading to membrane depolarization and activation of VDCC (40), but also upregulates Cav1.2 and Cav3.2 channels to enhance Ca2+ influx through L- and T-type VDCC (53). Furthermore, Ca2+ entries via store- and receptor-operated channels are also crucial for the altered Ca2+ homeostasis in acute hypoxic pulmonary vasoconstriction and chronic hypoxic pulmonary hypertension (29). Enhanced SOCE and ROCE are believed to be responsible for the chronic hypoxia-mediated increase in [Ca2+]cyt in PASMC, which subsequently results in sustained pulmonary vasoconstriction and concentric pulmonary arterial wall thickening (due to enhanced PASMC proliferation and migration).

Although it induces pulmonary vasoconstriction, acute hypoxia causes systemic (e.g., coronary, cerebral and renal) vasodilation (32). Chronic hypoxia, or prolonged exposure to hypoxia, also causes different responses between pulmonary and systemic (coronary, cerebral, and mesenteric) arterial smooth muscle cells (4, 7, 66). The distinct changes in [Ca2+]cyt induced by hypoxia are closely correlated with the diversity of hypoxic contractile responses in pulmonary and systemic artery smooth muscle cells. Hypoxia triggered increases in [Ca2+]cyt in PASMC, whereas it resulted in decreases in [Ca2+]cyt in renal (systemic) artery smooth muscle cells (57). Likewise, hypoxia can increase [Ca2+]cyt in PASMC, but not in mesenteric artery smooth muscle cells (42). Thus, hypoxia may differentially regulate selected proteins that participate in forming SOCC and ROCC, leading to diverse Ca2+ and contractile responses in pulmonary and systemic artery smooth muscle cells. In this study, we investigated and compared the basic expression and function of various cation channels and transporters, or the machinery of Ca2+ signaling cascade in human CASMC and PASMC, and their response to hypoxia. These data provide important information for our understanding of the molecular mechanisms responsible for the hypoxia-induced increase in [Ca2+]cyt in PASMC and the diversity of the hypoxic response between pulmonary and coronary artery smooth muscle cells. These data may also help to provide insight into developing novel therapeutic targets for pulmonary hypertension.

METHODS AND MATERIALS

Cell culture and hypoxia treatment.

Human pulmonary artery smooth muscle cells (PASMC) and coronary artery smooth muscle cells (CASMC) were purchased from Lonza (Walkersville, MD). The cells were initially isolated from normal subjects who were of the same sex and race. PASMC and CASMC were cultured at 37°C under a humidified 5% CO2 atmosphere in the smooth muscle cell growth medium (SmGM) including the smooth muscle cell basal medium (SmBM, CC-3181, Lonza) supplemented with SmGM-2 SingleQuots (CC-4149, Lonza). Cells grown at passage 5–8 were used in the experiments. For in vitro hypoxic experiments, PASMC and CASMC were cultured in an incubator equilibrated with 3% O2 (in N2), while control cells were cultured in an incubator equilibrated with room air (21% O2).

[Ca2+]cyt measurements.

[Ca2+]cyt measurements were performed as described previously (46). Briefly, human PASMC and CASMC were grown to confluence on 25-mm round glass coverslips. The cells were loaded with 4 μM fura-2 acetoxymethyl ester (fura-2/AM; Invitrogen/Molecular Probes, Eugene, OR) in the dark for 60 min at room temperature (22–24°C) in normal physiological salt solution (PSS). The PSS contained 140 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl2, 1.2 mM MgCl2, 10.0 mM glucose, and 10.0 mM HEPES. A coverslip containing fura-2/AM-loaded cells was placed in a recording chamber mounted on the stage of the Nikon inverted fluorescence microscope (Eclipse Ti-E; Nikon, Tokyo, Japan). The excitation wavelengths were 340 nm and 380 nm, and the emission signal at 520 nm was detected using an EM-CCD camera (Evolve; Photometrics, Tucson, AZ), a Nikon S-Plan Fluor ELWD ×20/0.45 objective lens and NIS Elements 3.2 software (Nikon). [Ca2+]cyt within the region of interest (5 × 5 μm), which was positioned at the peripheral region of each cell, was measured as the ratio of fluorescence intensities (F340/F380) and recorded every 2 s. [Ca2+]cyt was calculated by the ratiometric method using the following equation: [Ca2+]cyt = Kd × (Sf2/Sb2) × (R − Rmin)/(Rmax − R), where Kd (225 nM) is the dissociation constant of fura-2 for Ca2+ and Sf2 and Sb2 are the fluorescent intensities at 380-nm excitation in Ca2+-free (with EGTA) and Ca2+-saturated (using ionomycin) solutions, respectively. R is the measured fluorescence ratio, while Rmin and Rmax are the minimal and maximal ratios that were determined in cells superfused with the Ca2+-free solution (plus 5 mM EGTA) with 2 μM ionomycin and the bath solution containing 11 mM CaCl2, respectively. In some experiments, Ca2+ signals (R/R0) were determined as the ratio of fluorescence intensities (R) divided by the average baseline ratio (R0) (10, 47). In Ca2+-free solution, CaCl2 was replaced by equimolar MgCl2, and 0.1 mM EGTA was added to chelate residual Ca2+. All experiments for measurement of [Ca2+]cyt were performed at room temperature (22–24°C).

Protein preparation and Western blotting.

Human PASMC and CASMC were lysed in RIPA buffer (Thermo Scientific, Rockford, IL) supplemented with a protease inhibitor cocktail (Roche, Mannheim, Germany). The cell lysate was centrifuged at 13,000 rpm for 10 min at 4°C, and the supernatants were used as sample protein. An equal amount of proteins (30 μg) from each cell type was separated on SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Bio-Rad, Munich, Germany). After blocking with 5% skim milk in Tris-buffered saline supplemented with 0.1% Tween 20 for 1 h at room temperature, the membranes were incubated at 4°C overnight with primary antibody against STIM1 (diluted 1:1,000; catalog no. 4119, Prosci, Poway, CA) (62), STIM2 (diluted 1:1,000; catalog no. S8572, Sigma, St. Louis, MO) (48), Orai1 (diluted 1:1,000; catalog no. ACC-060, Alomone, Jerusalem, Israel) (18, 69), Orai2 (diluted 1:1,000; catalog no. ACC-061, Alomone) (18), and TRPC6 (diluted 1:1,000; catalog no. ACC-120, Alomone) (27). The membranes were then incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technology, Beverly, MA) at 1:5,000 dilution for 30 min at room temperature. The protein level was normalized to β-actin (1:5,000; Santa Cruz Biotechnology, Santa Cruz, CA). The gel bands were visualized with Amersham ECL prime Western blotting detection reagent (GE Healthcare, Little Chalfont, UK), and then the band density was quantified with ImageJ software (National Institutes of Health, Bethesda, MD).

Immunofluorescence.

Human PASMC and CAMSC were seeded onto 14-mm coverslips at a density of 2 × 104 cells per coverslip. After the hypoxia treatment, the cells were washed twice with PBS and fixed with a 4% formaldehyde solution for 20 min at room temperature. Cells were then washed twice with PBS and permeabilized with 0.5% Triton X-100 in PBS for 10 min. Unspecific binding was reduced by blocking with 5% bovine serum albumin (BSA; Sigma) in PBS for 60 min. Cells were incubated overnight at 4°C with a mouse monoclonal anti-Orai1 antibody (1:100, catalog no. ALM-025, Alomone) (34) and rabbit polyclonal anti-STIM2 antibody (1:200; catalog no. ab59342, Abcam, Cambridge, MA) (3). After incubation, cells were extensively washed with 1% BSA in PBS for 10 min 3 times. The cells were then incubated with secondary antibodies with Hoechst (1:1,000, Thermo Scientific) in 1% BSA in PBS for 60 min at room temperature. A goat anti-mouse IgG highly cross-adsorbed secondary antibody conjugated with Alexa Fluor 594 (1:1,000, Thermo Scientific) was used to display Orai1 fluorescence image, and donkey anti-rabbit IgG highly cross-adsorbed secondary antibody conjugated with Alexa Fluor 488 (1:1,000, Thermo Scientific) was used to display STIM2 fluorescence image. Coverslips were then mounted with Prolong Diamond Antifade mountant (Molecular Probes), and images were taken on a Nikon Eclipse Ti-E inverted fluorescence microscope. All images were acquired under identical imaging conditions using identical acquisition parameters. Quantitative analysis of fluorescence was performed with Image-Pro Plus 5.0 (Media Cybernetics, Silver Spring, MD). The integrated optical density (IOD) was calculated.

Analysis of mitochondrial bioenergetics and cellular glycolysis.

The XF24 Analyzer (Seahorse Biosciences, North Billerica, MA) was used to measure O2 consumption rate (mitochondrial stress test) and extracellular acidification rate (glycolysis stress test) according to the manufacturer’s instructions. All the drugs used in the study were from the XF Cell Mito Stress Test Kit and XF Cell Glycolysis Stress Test Kit (Seahorse Biosciences). CASMC and PASMC were seeded into XF24 Cell Culture Microplates (Seahorse Biosciences) at their previously optimized density of 30,000 cells per well (0.275 cm2) and allowed to adhere overnight. The cells were incubated at 37°C in a CO2-free XF prep station 60 min before the Seahorse assay to allow the cells to equilibrate with the assay medium. For the mitochondrial stress test, drugs were injected in the following order: oligomycin (an ATP synthase inhibitor), FCCP (carbonyl cyanide-4-trifluoromethoxy phenylhydrazone, an electron transport chain accelerator), and rotenone-antimycin A combination (mitochondrial Complex 1 and III inhibitors). Normalization was performed by determining the protein concentration. ATP-linked oxygen consumption was determined as the difference between the baseline oxygen consumption rate (OCR) and the post-oligomycin minimum OCR. For the glycolysis stress test, CASMC and PASMC were glucose-starved in XF assay medium in a CO2-free XF prep station at 37°C for 60 min and then sequentially injected with glucose, oligomycin, and 2-deoxy-d-glucose (2-DG; glycolysis inhibitor). Glycolytic capacity was determined as the difference between the acidification rate before the addition of d-glucose and that obtained in the presence of oligomycin.

Drugs and chemicals.

1-Oleoyl-2-acetyl-sn-glycerol (OAG) was purchased from Cayman Chemical (Ann Arbor, MI) and was supplied as a solution in acetonitrile. Adenosine 5-triphosphate disodium salt hydrate (ATP) and histamine were prepared as concentrated stock solutions in distilled water. Cyclopiazonic acid (CPA) was prepared as a concentrated stock solution in dimethyl sulfoxide (DMSO). Ryanodine was purchased from Abcam and soluble in ethanol. All stocks were aliquoted and kept at −20°C and were diluted into PSS on the day of use. All reagents used were obtained from Sigma-Aldrich unless mentioned otherwise.

Statistical analysis.

Data are expressed as means ± SE. Statistical significance between two or among multiple groups was performed using Student’s t-test or one-way analysis of variance followed by Tukey’s multiple comparison post hoc test, respectively. Differences were considered to be significant when P < 0.05.

RESULTS

Resting [Ca2+]cyt is comparable in CASMC and PASMC.

We first compared the resting [Ca2+]cyt level between human CASMC and PASMC. As shown in Fig. 1, A and B, the resting [Ca2+]cyt was not significantly different between CASMC (85.07 ± 0.71 nM) and PASMC (89.80 ± 0.94 nM) cultured under the same conditions. The histogram of the resting [Ca2+]cyt in CASMC and PASMC showed a similar distribution with almost overlapped fitting curves in both cell types (Fig. 1A).

Fig. 1.

Fig. 1.

Comparison of the resting cytosolic free Ca2+ concentration ([Ca2+]cyt) and basal metabolism between CASMC and PASMC. A: histogram showing the distribution of the resting [Ca2+]cyt in CASMC (blue bars) and PASMC (red bars). The peak values of the resting [Ca2+]cyt based on the fitting curves are 85.07 nM and 89.8 nM in coronary (CASMC) and pulmonary (PASMC) artery smooth muscle cells, respectively. B: summarized data (means ± SE) showing the averaged resting [Ca2+]cyt in CASMC (n = 1,084 cells from 27 coverslips of cells) and PASMC (n = 789 cells from 27 coverslips of cells). C: the Seahorse XF24 analyzer was used to measure and compare oxygen consumption rate (OCR) in CASMC and PASMC (30,000/0.275 cm2). Summarized data (mean ± SE) showing the basal mitochondrial respiration and the O2 consumed for ATP production in CASMC and PASMC (n = 20 measurements). D: the Seahorse XF24 analyzer was used to measure extracellular acidification rate (ECAR, mpH/min) in CASMC and PASMC (30,000/0.275 cm2). d-Glucose (Gluc, 2 mg/ml), oligomycin (Oligo, 1 μM), and 2-deoxy-d-glucose (2-DG, 100 mM) were added at the time indicated by arrows. E: summarized data (means ± SE) showing the basal glycolytic rate (left) determined as the difference between basal ECAR and that obtained in the presence of d-glucose and the maximal glycolytic capacity (right) determined as the difference between the obtained in the presence of oligomycin and that after the addition of 2-DG (n = 20 measurements). *P < 0.05 vs. CASMC.

Basal metabolism between CASMC and PASMC.

In CASMC and PASMC, OCR was measured and compared with estimate mitochondrial bioenergetics. Our data identified a similar level of basal respiration between CASMC and PASMC (Fig. 1C). In addition, there was no significant difference in the decrease in OCR between CASMC and PASMC exposed to oligomycin (Fig. 1C). Extracellular acidification rates (ECAR) were monitored to reflect glycolysis. There was no difference in the glycolytic rate between CASMC and PASMC in the absence of substrate (Fig. 1D). However, the addition of d-glucose caused a marked increase in ECAR in PASMC that was significantly greater than the increase in CASMC (Fig. 1, D and E). The oligomycin-mediated increase in ECAR was also significantly greater in PASMC than in CASMC (Fig. 1D). The maximal glycolytic capacity, determined as the difference in ECAR between ECAR obtained in the presence of oligomycin and that after the addition of 2-deoxy-d-glucose (2-DG), was significantly higher in PASMC than in CASMC (Fig. 1E, right). The glycolytic inhibitor, 2-deoxy-d-glucose, reduced the acidification rate in both CASMC and PASMC to the same extent (Fig. 1D).

The changes in [Ca2+]cyt due to CPA-induced SOCE and OAG-induced ROCE in CASMC and PASMC.

We first measured and compared the amplitude of increases in [Ca2+]cyt due to SOCE in CASMC and PASMC. In the absence of extracellular Ca2+ (0Ca), blockade of the sarcoplasmic reticulum (SR)/endoplasmic reticulum (ER) Ca2+-pump (SERCA) with cyclopiazonic acid (CPA) (10 μM) induced a transient increase in [Ca2+]cyt due to Ca2+ leakage from the SR in CASMC and PASMC. The amplitude of CPA-induced transient increases in [Ca2+]cyt reflects the level of [Ca2+] stored in the SR, especially the IP3-sensitive SR stores. Stored [Ca2+] in the SR, or the amplitude of CPA-induced transient increase in [Ca2+]cyt in the absence of extracellular Ca2+, seemed to be comparable in CASMC and PASMC (Fig. 2, A and B). Then we measured and compared the amplitude of SOCE by determining the increase in [Ca2+]cyt upon reintroduction of 1.8 mM external Ca2+ in the presence of CPA. We observed that the second increase in [Ca2+]cyt due to SOCE (upon extracellular Ca2+ restoration) in CASMC was slightly, but statistically significantly, greater than in PASMC (Fig. 2, A and Ba). We also determined the maximum change of [Ca2+]cyt in R/R0, which displayed a similar trend (Fig. 2Bb).

Fig. 2.

Fig. 2.

Comparison of cyclopiazonic acid (CPA)-induced store-operated Ca2+ entry (SOCE) and OAG-induced receptor-operated Ca2+ entry (ROCE) between CASMC and PASMC. A and B: representative records (A) and summarized data (Ba, means ± SE) showing changes of [Ca2+]cyt in response to CPA (an inhibitor of SERCA, 10 μM) in the absence (0Ca) or presence (1.8Ca) of 1.8 mM extracellular Ca2+ in CASMC (n = 237 cells from 7 coverslips of cells) and PASMC (n = 249 cells from 7 coverslips of cells). The calculated changes of [Ca2+]cyt in R/R0 are shown in b. C: representative records showing changes in [Ca2+]cyt in response to OAG (an analog of diacylglycerol, 100 μM) in CASMC and PASMC. D: summarized data (means ± SE) showing the amplitude (a) and the area under the curve (AUC, b) of increases in [Ca2+]cyt and the percentage of responsive cells (c) in CASMC (n = 391 cells from 8 coverslips of cells) and PASMC (n = 319 cells from 8 coverslips of cells). The calculated changes of [Ca2+]cyt in R/R0 are shown in d. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. CASMC.

Extracellular application of the membrane-permeable diacylglycerol (DAG) analogue, 1-oleoyl-2-acetyl-sn-glycerol (OAG, 100 μM), can directly activate ROCC and induce ROCE. The amplitude of OAG-induced ROCE in CASMC was significantly higher compared with PASMC, with R/R0 also exhibiting a similar trend (Fig. 2, Bb and Dd). Furthermore, the area under the curve (AUC) of the OAG-mediated increase in [Ca2+]cyt, which represents the total amount of Ca2+ that enters the cells, was significantly greater in CASMC than in PASMC (Fig. 2, C and D). The proportion of responsive cells in CASMC was also higher than in PASMC (Fig. 2D). These results indicate that the amplitudes of CPA-induced SOCE and the OAG-induced ROCE in CASMC were greater than in PASMC.

ATP-induced increase in [Ca2+]cyt is greater in CASMC than in PASMC.

ROCE was also evaluated by changes in [Ca2+]cyt upon exposure to the receptor agonist ATP. ATP binds to purinergic receptors, stimulating phospholipase C to produce IP3 and DAG. DAG is a known second messenger that directly opens ROCC to induce ROCE, while IP3 activates the IP3 receptors in the SR, thus producing Ca2+ release and store depletion causing SOCE. Of the responding cells, we observed three patterns of ATP-mediated increases in [Ca2+]cyt in CASMC and PASMC: 1) a transient increase (pattern 1), 2) a transient increase followed by a plateau or sustained increase (pattern 2), and 3) an oscillatory increase (pattern 3) (Fig. 3A). The amplitude of ATP-induced increases in [Ca2+]cyt showed no significant difference between CASMC and PASMC, while the AUC and frequency of Ca2+ oscillations induced by ATP were more significant in CASMC than in PASMC (Fig. 3B). Patterns 1, 2, and 3 changes in [Ca2+]cyt were analyzed together for calculation of AUC. Most of the CASMC (60%) and PASMC (67%) exhibited pattern 2 increases in [Ca2+]cyt in response to extracellular application of ATP (Fig. 3C); the proportion of responsive cells in CASMC was also higher than in PASMC (Fig. 3D). The dose-response curves of ATP-induced increases in [Ca2+]cyt showed significant differences between CASMC and PASMC (Fig. 3E). In CASMC, ATP increased [Ca2+]cyt at the dose ranging from 10−8 to 10−7 M and the estimated EC50 was ~0.2 μM (Fig. 3E). In PASMC, ATP increased [Ca2+]cyt at the concentration ranging from 10−6 to 10−5 M with an estimated EC50 of 15 μM (Fig. 3E). These data indicate that CASMC are more sensitive to ATP than PASMC.

Fig. 3.

Fig. 3.

Comparison of ATP- and histamine-induced increases in [Ca2+]cyt in CASMC and PASMC. A: representative records showing different patterns of [Ca2+]cyt changes in CASMC and PASMC before and during application of 100 μM ATP. B: summarized data (means ± SE) showing the amplitude (left) and the area under the curve (middle, AUC) of increases in [Ca2+]cyt and frequency (right) of ATP-induced [Ca2+]cyt oscillations in CASMC and PASMC. Patterns 1, 2, and 3 changes of [Ca2+]cyt were analyzed together for the calculation of AUC. C: summarized data showing the percentage of cells exhibiting different patterns (patterns 1, 2, 3) of [Ca2+]cyt changes induced by ATP in CASMC (CA) and PASMC (PA). D: summarized data (means ± SE) showing the percentage of responsive cells in CASMC (n = 379 cells from 8 coverslips) and PASMC (n = 312 cells from 8 coverslips). E: normalized dose-response curves of ATP-induced increases in [Ca2+]cyt (means ± SE for each data point) in CASMC (blue circles) and PASMC (red circles). F: representative records showing different patterns of [Ca2+]cyt changes in CASMC and PASMC before and during application of 100 μM histamine (Hist). G: summarized data (means ± SE) showing the amplitude (left) and the area under the curve (middle, AUC) of increases in [Ca2+]cyt and frequency (right) of Hist-induced [Ca2+]cyt oscillations in CASMC and PASMC. H: summarized data showing the percentage of cells exhibiting different patterns (patterns 1, 2, 3) of [Ca2+]cyt changes induced by Hist in CASMC and PASMC. I: summarized data (means ± SE) showing the percentage of responsive cells in CASMC (n = 379 cells from 8 coverslips) and PASMC (n = 274 cells from 8 coverslips). *P < 0.05, **P < 0.01 and ***P < 0.001 vs. CASMC.

Histamine-induced increase in [Ca2+]cyt in CASMC and PASMC.

ROCE was also evaluated by changes in [Ca2+]cyt upon exposure to the receptor agonist histamine. Similar to the ATP-mediated changes, there are three patterns of the increases in [Ca2+]cyt in response to histamine in CASMC and PASMC: 1) a transient increase (pattern 1), 2) a transient increase followed by a plateau or sustained increase (pattern 2), and 3) an oscillatory increase (pattern 3) (Fig. 3F). The histamine-mediated increase in [Ca2+]cyt (in terms of both amplitude and AUC) in CASMC is greater than in PASMC (Fig. 3G). More CASMC (72%) exhibited pattern 2 increases in [Ca2+]cyt in response to extracellular application of histamine than PASMC (48%) (Fig. 3H); the percentage of responsive cells in CASMC (97%) was also higher than in PASMC (80%) (Fig. 3I). These results imply that CASMC are more sensitive to histamine than PASMC.

The increase in [Ca2+]cyt due to Na+/Ca2+ exchange in CASMC and PASMC.

The activity of Na+/Ca2+ exchangers (NCX) in the plasma membrane depends predominantly on the transmembrane Na+ gradient. Removal of extracellular Na+ reverses the transmembrane Na+ gradient to favor Na+ extrusion and Ca2+ entry via the reverse mode of Na+/Ca2+ exchange. As shown in Fig. 4A, removal of extracellular Na+ using an equimolar concentration NMDG+ resulted in two patterns of increases in [Ca2+]cyt: 1) a transient increase (pattern 1) and 2) an oscillatory increase (pattern 3). The amplitude of the transient increase in [Ca2+]cyt (pattern 1) and the frequency of the oscillatory increase in [Ca2+]cyt (pattern 3) due to the inward transportation of Ca2+ through NCX were not different between CASMC and PASMC; however, the AUC, an indicator of the total amount of Ca2+ entering the cell, of the NCX-associated inward transportation of Ca2+ in CASMC was significantly larger than in PASMC (Fig. 4B). More CASMC (80%) exhibited Ca2+ oscillations (pattern 3) when extracellular Na+ was removed than PASMC (60%) (Fig. 4C).

Fig. 4.

Fig. 4.

Comparison of increases in [Ca2+]cyt due to inward Ca2+ transportation through Na+/Ca2+ exchanger (NCX) in CASMC and PASMC. A: representative records showing different patterns of [Ca2+]cyt changes (patterns 1 and 3) in CASMC and PASMC by removal of extracellular Na+ (0Na). B: summarized data (means ± SE) showing the amplitude (left) and AUC (middle) of increases in [Ca2+]cyt and frequency (right) of Na+-free medium-induced [Ca2+]cyt oscillations in CASMC and PASMC. C: summarized data showing the percentage of cells exhibiting different patterns of [Ca2+]cyt changes induced by removal of extracellular Na+ in CASMC and PASMC. D: summarized data (means ± SE) showing the percentage of responsive cells in CASMC (n = 212 cells from 8 coverslips) and PASMC (n = 179 cells from 8 coverslips). E: representative records showing different patterns of [Ca2+]cyt changes induced by removal of extracellular Na+ in the presence of 50 μM ryanodine (an RyR inhibitor) in CASMC and PASMC. F: summarized data (means ± SE) showing the amplitude (left) and AUC (middle) of increases in [Ca2+]cyt and the frequency (right) of Na+-free medium-induced [Ca2+]cyt oscillations in CASMC and PASMC. G: summarized data showing the percentage of cells exhibiting a different pattern of [Ca2+]cyt changes induced by removal of extracellular Na+ in the presence of 50 μM ryanodine in CASMC and PASMC. H: summarized data (means ± SE) showing the percentage of responsive cells in CASMC (n = 385 cells from 6 coverslips) and PASMC (n = 379 cells from 6 coverslips). ***P < 0.001 vs. CASMC.

The local increase in [Ca2+]cyt due to inward Ca2+ transportation via the reverse mode of NCX may trigger the Ca2+-induced Ca2+ release (CICR) by activating ryanodine receptors (RyR) on the SR membrane. Therefore, the increase in [Ca2+]cyt by removal of extracellular Na+ is composed of both inward Ca2+ transportation due to NCX and CICR. To specifically determine and compare the increases in [Ca2+]cyt via inward Ca2+ transportation through NCX, we repeated the experiments described above in the presence of 50 μM ryanodine (which inhibits RyR at this dose). As shown in Fig. 4, E–H, the amplitude and AUC of the NCX-associated transient increases in [Ca2+]cyt and the frequency of the NCX-associated oscillatory increases in [Ca2+]cyt were comparable in CASMC and PASMC (Fig. 4, E and F). The percentage of cells exhibiting pattern 1 (transient increase) and pattern 3 (oscillatory increase) changes of [Ca2+]cyt is also similar in CASMC and PASMC (Fig. 4G); the percentage of responsive cells, however, was higher in CASMC than in PASMC (Fig. 4H). The area under the curve (AUC) of RyR-associated increase in [Ca2+]cyt was determined by subtracting the AUC of the increase in [Ca2+]cyt induced by removal of extracellular Na+ from the increase in [Ca2+]cyt induced by ryanodine. The increase in [Ca2+]cyt by inward Ca2+ transportation via NCX was comparable in CASMC and PASMC, while the AUC in [Ca2+]cyt due to Ca2+-induced Ca2+ release (CICR) via RyR was greater in CASMC than in PASMC. These data suggest that, by inhibition of CICR through RyR, CASMC and PASMC exhibit similar inward Ca2+ transportation via NCX. It is possible that RyR is more active or the expression level of RyR is greater in CASMC than in PASMC.

Hypoxia upregulates protein expression of SOCC and ROCC in PASMC, but not in CASMC.

We examined and compared the protein expression level of STIM1/STIM2 and Orai1/Orai2, which are believed to form SOCC responsible for SOCE, as well as the level of TRPC6, which contributes to forming ROCC, in normoxic control CASMC/PASMC with hypoxic CASMC/PASMC. Consistent with the functional experiments (Fig. 2), our Western blot experiments showed that protein expression levels of STIM1/STIM2, Orai1/Orai2 and TRPC6 were significantly higher in CASMC than in PASMC (Fig. 5, A and B). These results indicate that the basal expression of the proteins participating in the formation of SOCC (e.g., STIM1/2 and Orai1/2) and ROCC (e.g., TRPC6) is higher in CASMC than in PASMC. The Western blot experimental data are consistent with the functional data showing that the amplitudes of CPA-induced SOCE and OAG-induced ROCE are greater in CASMC than in PASMC.

Fig. 5.

Fig. 5.

Comparison of basal protein expression levels of store-operated Ca2+ channels (SOCC) (STIM1/2, Orai1/2) and ROCC (TRPC6) and hypoxia-induced changes of protein expression of SOCC (STIM1/2, Orai1/2) and ROCC (TRPC6) in CASMC and PASMC. A and B: representative images (A) and summarized data (B, means ± SE) showing Western blot analysis of STIM1, STIM2, Orai1, Orai2, and TRPC6 in CASMC and PASMC (n = 5 separate experiments). β-Actin was used as a control. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. CASMC. C and D: representative images (C) and summarized data (D, means ± SE) showing Western blot analysis of STIM1, STIM2, Orai1, Orai2, and TRPC6 in CASMC and PASMC under normoxic (Nor) and hypoxic (Hyp) conditions (n = 5 separate experiments for each group). β-Actin was used as a control. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. normoxic CASMC. #P < 0.05, ##P < 0.01, and ###P < 0.001 vs. normoxic PASMC.

Prolonged hypoxia (for 72 h) markedly upregulated the protein expression of STIM1/STIM2, Orai1/Orai2, and TRPC6 in PASMC, but not in CASMC (Fig. 5, C and D). These data show that exposure to hypoxia selectively increases expression of proteins involved in SOCE and ROCE in PASMC, but not in CASMC. The hypoxia-induced upregulation of STIM1/2, Orai1/2, and TRPC6 may be one of the unique characteristics of PASMC, in comparison to CASMC.

Effect of prolonged hypoxia on STIM2 and Orai1 immunofluorescence in CASMC and PASMC.

We also determined and compared the protein expression levels of STIM2 and Orai1 using immunofluorescence assay. The fluorescence intensities of STIM2 and Orai1 are shown in Fig. 6, A and B, which was consistent with the Western blot results shown in Fig. 5, C and D. Chronic or prolonged hypoxia significantly increased the protein expression level of STIM2 and Orai1 in PASMC, but there was no significant difference in the fluorescence intensity of STIM2 and Orai1 between normoxic and hypoxic CASMC. As shown in Fig. 6C, line scans also showed a marked increase in the fluorescence intensities of STIM2 and Orai1 in PASMC exposed to hypoxia (in comparison to normoxic control PASMC), but not in CASMC exposed to hypoxia (in comparison to normoxic control CASMC). The line scan region is indicated in Fig. 6A. STIM2 is a Ca2+ sensor expressed in the SR/ER membrane that is mainly involved in the regulation of the resting [Ca2+]cyt and ER Ca2+ levels (8). Previous studies have suggested that compared with STIM1, STIM2 is more sensitive to small changes in the ER [Ca2+] due to its lower affinity for Ca2+ (6, 38). Ong et al. (38) have demonstrated that STIM2 promotes STIM1 clustering and recruits STIM1 to ER-PM junctions at low stimulus intensities when ER Ca2+ depletion is minimal, thus enhancing interaction with Orai1 and activating SOCE, suggesting that STIM2 is a critical protein that determines STIM1 clustering. Moreover, Orai1 is the main and essential pore-forming subunit of SOCC (41). The next set of experiments was designed to test whether the hypoxia-induced upregulation of STIM2 and Orai1 in PASMC would increase the basal [Ca2+]cyt.

Fig. 6.

Fig. 6.

Hypoxia increases protein level (determined by immunofluorescence intensity) of STIM2 and Orai1 only in PASMC, but not in CASMC. A and B: representative images (A) and summarized data (B, means ± SE) showing STIM2 (green) and Orai1 (red) level in CASMC (top) and PASMC (bottom) under normoxic (Nor) and hypoxic (Hyp) conditions. The cells were dual-labeled with the anti-STIM2 antibody (green) and Orai1 antibody (red). Nuclei were stained with Hoechst (blue). Experiments were performed in 4 separate immunostaining procedure. **P < 0.01 vs. Nor. C: line scans showing the distribution of green (STIM2) and red (Orai1) fluorescence intensity among selected CASMC (left) and PASMC (right) under normoxic (Nor, blue lines) and hypoxic (Hyp, red lines). The line scan region in the field is shown as a broken white line in each image panel.

Hypoxia results in significant increase in the resting [Ca2+]cyt in PASMC, but not in CASMC.

We measured and compared the resting [Ca2+]cyt in normoxic CASMC/PASMC and hypoxic CASMC/PASMC. Exposure of CASMC to hypoxia had no significant effect on the basal [Ca2+]cyt level (normoxia: 88.53 ± 1.63 nM; hypoxia: 90.95 ± 1.17 nM) (Fig. 7, A and B). There was no shift in the histogram showing the resting [Ca2+]cyt distribution in hypoxic CASMC compared with normoxic CASMC (Fig. 7A). In contrast, the basal [Ca2+]cyt in PASMC was significantly increased by exposure to hypoxia (Fig. 7, C and D). The histogram showing the resting [Ca2+]cyt distribution in hypoxic PASMC was shifted to the right in comparison to normoxic PASMC, while the resting [Ca2+]cyt in PASMC was significantly increased from 90.43 ± 1.23 nM (normoxia) to 146.78 ± 2.36 nM (hypoxia, P < 0.001) (Fig. 7, C and D). These results indicate that hypoxia selectively increases the resting [Ca2+]cyt in PASMC, but not in CASMC.

Fig. 7.

Fig. 7.

Hypoxia increases the resting [Ca2+]cyt in PASMC, but not in CASMC. A: histogram showing the distribution of the resting [Ca2+]cyt in normoxic (dark green bars) and hypoxic (dark red bars) CASMC. The peak values of the resting [Ca2+]cyt based on the fitting curves are 88.53 nM and 90.95 nM in normoxic (Nor, n = 233 cells from 6 coverslips) and hypoxic (Hyp, n = 371 cells from 9 coverslips) CASMC, respectively. B: summarized data (means ± SE) showing the averaged resting [Ca2+]cyt in normoxic (n = 233 cells from 6 coverslips) and hypoxic (n = 371 cells from 9 coverslips) CASMC. C: histogram showing the distribution of the resting [Ca2+]cyt in Nor (dark green bars) and Hyp (dark red bars). The peak values of the resting [Ca2+]cyt based on the fitting curves are 90.43 nM and 146.78 nM in normoxic (n = 320 cells from 8 coverslips) and hypoxic (n = 281 cells from 8 coverslips) PASMC, respectively. D: summarized data (means ± SE) showing the averaged resting [Ca2+]cyt in normoxic (n = 320 cells from 8 coverslips) and hypoxic (n = 281 cells from 8 coverslips) PASMC. Statistical significance between two groups was evaluated using Student’s t-test. ***P < 0.001 vs. Nor.

DISCUSSION

The results from this study demonstrate that: 1) The basal [Ca2+]cyt was comparable in CASMC and PASMC under resting conditions; 2) the mitochondrial bioenergetics (e.g., basal respiration and ATP production) were also similar between CASMC and PASMC; 3) glycolysis was significantly higher in PASMC than in CASMC; 4) SOCE/ROCE is slightly, but significantly, greater in CASMC than in PASMC under normoxic conditions, which was due apparently to a higher expression of STIM1/2, Orai1/2, and TRPC6 in CASMC than in PASMC; 5) the increase in [Ca2+]cyt by inward Ca2+ transportation via Na+/Ca2+ exchangers was comparable in CASMC and PASMC, while the rise in [Ca2+]cyt due to Ca2+-induced Ca2+ release via RyR was greater in CASMC than in PASMC; and 6) most interestingly, hypoxia had a negligible effect on protein expression of SOCC/ROCC (STIM1/STIM2, Orai1/Orai2, and TRPC6) and the resting [Ca2+]cyt in CASMC, but significantly upregulated SOCC/ROCC and increased the resting [Ca2+]cyt in PASMC. Collectively, these data imply that it is a unique intrinsic characteristic or feature for PASMC to respond to hypoxia by upregulating cation channels responsible for SOCE/ROCE. These data also provide one of the important explanations why hypoxia causes pulmonary vasoconstriction and induces pulmonary vascular remodeling, but causes coronary vasodilation.

The pulmonary circulation system is very different in many aspects from the systemic (e.g., coronary) circulation system. The pulmonary circulation is a high-flow, low-resistance, and low-pressure system; the pulmonary arterial pressure is typically about one-fifth to one-sixth of the systemic arterial pressure. The primary function of the pulmonary artery is to deliver the deoxygenated venous blood to the lung for gas exchange or reoxygenation of the venous blood. The primary function of the coronary artery is to deliver the oxygenated arterial blood to cardiomyocytes (17, 50, 71). Thus, tissue hypoxia causes coronary vasodilation to increase blood flow to provide more oxygen and nutrients to heart muscle for maintaining heart function, whereas alveolar hypoxia causes pulmonary vasoconstriction to maintain an optimal ventilation/perfusion match for maximal oxygenation of the venous blood (15, 56, 57). Prolonged alveolar hypoxia, in patients with chronic obstructive lung disease or inhabitants living at high altitude, can cause sustained pulmonary vasoconstriction and pulmonary vascular remodeling, and ultimately pulmonary hypertension. Thus, the mechanisms by which hypoxia induces pulmonary vasoconstriction and coronary vasodilation are therefore an active area of research. There are, however, still no adequate explanations for the mechanisms responsible for hypoxia-induced pulmonary vasoconstriction and coronary vasodilation.

An increase in [Ca2+]cyt in PASMC due to Ca2+ entry through Ca2+ channels and/or transporters in the plasma membrane is a major trigger for pulmonary vasoconstriction and an important stimulus for PASMC migration and proliferation that contribute to pulmonary vascular remodeling. A sustained increase in the resting [Ca2+]cyt in PASMC is one of the indispensable prerequisites for enhancing PASMC proliferation in patients with idiopathic pulmonary arterial hypertension and animals with hypoxia-induced pulmonary hypertension. Recent evidence suggests that STIM1-mediated recruitment of Orai1/2 forms SOCC in the plasma membrane and induces SOCE. Active depletion of intracellular Ca2+ stores, such as the IP3-sensitive SR, by agonists or growth factors that stimulate IP3 synthesis, or passive depletion of the SR by inhibiting the SR Ca2+ pump with CPA, promotes STIM1 to polymerize and then translocate to the puncta area, where STIM1 interacts with Orai1 and facilitates to form tetrameric Orai1 channels to induce SOCE (9, 11, 14, 36). STIM2 shares similar structure with STIM1, but the sensitivity of STIM2 to changes of intracellularly stored [Ca2+] in the SR is much greater than that of STIM1 (8, 70). Therefore, a very small decrease in [Ca2+] in the SR is sufficient to activate STIM2 and ultimately stimulate Ca2+ entry through Orai1/2 channels. It has therefore been proposed that STIM1 is mainly involved in the regulation of store depletion-mediated Ca2+ entry, while STIM2 is predominantly involved in regulating the resting [Ca2+]cyt (8).

TRPC6 forms homotetrameric or heterotetrameric cation channels that are activated by DAG upon ligand-mediated activation of G protein-coupled receptors (GPCR) and tyrosine kinase receptors (21, 24). TRPC6-formed ROCCs can also be opened by the membrane-permeable DAG analogue, OAG, or by other signaling messengers involved in the G protein signal pathway (29). Knockdown of TRPC6 with siRNA decreased DAG-induced cation influx in rat PASMC (29). ATP and histamine can bind to the related GPCR to activate phospholipase C to produce DAG and IP3, which act synergistically to promote Ca2+ entry through ROCC and SOCC. In the present study, we determined the basic expression and function of various cation channels and transporters, or the machinery of Ca2+ signaling cascade, in human CASMC and PASMC. The data showed that the amplitudes of CPA-induced SOCE and OAG-induced ROCE in CASMC are slightly, but significantly, greater than in PASMC. The frequency and the area under the curve (AUC) of Ca2+ oscillations induced by ATP were larger in CASMC than in PASMC. Histamine-induced increase in [Ca2+]cyt (both amplitude and AUC) was also greater in CASMC than in PASMC. The greater increases in [Ca2+]cyt to Ca2+ entry through ROCC and SOCC are likely due to the slightly higher expression of TRPC6 (ROCC) and STIM1/Orai1/2 (SOCC) in CASMC than in PASMC. The results from this study also demonstrated that human CASMC and PASMC functionally express Na+/Ca2+ exchangers. The increase in [Ca2+]cyt due to the inward transportation of Ca2+ through Na+/Ca2+ exchangers is not significantly different between CASMC and PASMC under the resting conditions.

Intriguingly, one of the major differences between CASMC and PASMC is their response to hypoxia: prolonged hypoxia had a negligible effect on protein expression of SOCC (STIM1/Orai1/2) and ROCC (TRPC6) or the resting [Ca2+]cyt in CASMC, but it significantly upregulated SOCC and ROCC and increased the resting [Ca2+]cyt in PASMC. A wealth of data has been accumulated suggesting that STIM1 and Orai1/2 contribute to form SOCC responsible for SOCE and are upregulated in PASMC from patients with idiopathic pulmonary arterial hypertension and animals with experimental pulmonary hypertension, in comparison to controls (9, 11, 46). Our in vitro data showing that hypoxia increases the resting [Ca2+]cyt in PASMC, but not in CASMC, are consistent with the previous reports demonstrating the increased basal [Ca2+]cyt in hypoxic rat PASMC (29).

SOCE is one of the Ca2+ entry pathways responsible for the elevated basal [Ca2+]cyt in chronically hypoxic PASMC (29). There is growing evidence supporting the pivotal role of TRPC6 in acute hypoxia-induced pulmonary vasoconstriction (13, 58) and chronic hypoxia-induced pulmonary hypertension (29). Upregulation of TRPC6 and enhanced Ca2+ entry through ROCC have also been found in PASMC exposed to chronic hypoxia; knockdown of TRPC6 with siRNA attenuates the hypoxia-induced enhancement of ROCE (29, 39). TRPC6 mediates agonist-induced ROCE in vascular smooth muscle cells (20, 25). The TRPC6-formed ROCC appears to be expressed in systemic (e.g., coronary) vascular smooth muscle cells (19, 56); however, the protein expression cannot be upregulated by hypoxia. This is likely one of the reasons why hypoxia fails to increase [Ca2+]cyt and result in contractile responses in smooth muscle from the systemic circulation system (e.g., coronary arterial smooth muscle). These data also explain why hypoxia causes pulmonary vasoconstriction and coronary (or systemic) vasodilation and, furthermore, why prolonged hypoxia only causes pulmonary hypertension. Our previous data indicated that that Ca2+-sensing receptor (CaSR) might play a significant pathogenic role in the development and progression of sustained pulmonary vasoconstriction and concentric pulmonary arterial wall thickening in patients with idiopathic pulmonary arterial hypertension (IPAH) and animals with experimental pulmonary hypertension (63, 64). The mRNA and protein expression level of CaSR was upregulated, while the extracellular Ca2+-induced increase in [Ca2+]cyt was enhanced, in PASMC from patients with IPAH in comparison to normal controls (63). Importantly, CaSR functionally interacted with TRPC6 to mediate extracellular Ca2+-induced Ca2+ influx and increase in [Ca2+]cyt in IPAH-PASMC (52). Enhanced Ca2+ entry due to upregulated expression and enhanced function of CaSR contributes to enhancing Ca2+ signaling and activating Ca2+/CaM-sensitive transcription factors associated with PASMC proliferation and migration. It is therefore important to study the potential role of CaSR (and its functional interaction with STIM1/2, Orai1/2, and TRPC6) in the differential effects of hypoxia on Ca2+ signaling in PASMC and CASMC.

The mechanisms underlying differential responses to hypoxia in CASMC and PASMC, regarding protein expression of SOCC (STIM1/Orai1/2) and ROCC (TRPC6), are unknown. Activation of Notch signaling can potentially mediate transcriptional upregulation of genes encoding SOCC (e.g., TRPC6, and Orai1/2) in human PASMC, thus enhancing SOCE (65). Our recent study showed that hypoxia activates Notch signaling and upregulates TRPC6 channels; genetic deletion of the TRPC6 gene, trpc6 (trpc6−/−) significantly attenuates acute hypoxia-induced pulmonary vasoconstriction and chronic hypoxia-induced pulmonary hypertension. These data imply that Notch signaling may transcriptionally regulate TRPC6 and may hence exert a critical role in pulmonary hypertension (44). It is, however, unknown whether hypoxia or prolonged hypoxia activates Notch signaling in systemic arterial smooth muscle cells like CASMC. Furthermore, hypoxia increases hypoxia-inducible factors 1α (HIF-1α) and 2α (HIF-2α) in both systemic and pulmonary arterial smooth muscle cells (2, 26). The downstream targets of HIF-1α and HIF-2α may vary among different types of cells. In PASMC, hypoxia-induced upregulation of TRPC (e.g., TRPC1 and TRPC6) channels can be mediated by HIF-1α and/or HIF-2α, hypoxia-sensitive transcription factors that are known to be upregulated by increased superoxide as well (55, 60). Further studies are needed to define the different mechanisms responsible for hypoxia-mediated transcriptional, posttranscriptional, and/or translational regulation of ROCC (e.g., STIM1 and Orai1/2) and SOCC (e.g., TRPC6/TRPV1) channel genes in CASMC and PASMC.

Although effects of hypoxia on Ca2+ signaling and contractile response in the two types of vascular smooth muscle cells (CASMC and PASMC) have been described, the precise mechanisms involved in hypoxia (or oxygen) sensing and its downstream effectors (dependent or independent of HIF-1α/HIF-2α) are not well known. Substantial evidence has accumulated demonstrating that reactive oxygen species (ROS) can influence vascular smooth muscle [Ca2+]cyt (43, 56) and hypoxia can differentially regulate the production of cytoplasmic and mitochondrial ROS including superoxide in systemic and pulmonary vascular cells (1, 57). A recent report indicates that chronic hypoxia increases H2O2 generation in PASMC, and H2O2 is the pivotal regulator that ultimately acts to promote the expression and interaction of SOCC and function as the functional regulator in response to hypoxia (10). In contrast, hypoxia inhibits the effect of oxidants (including H2O2) and increases cellular reducing capacity, thereby reducing Ca2+ influx in systemic arteries (15). Wu et al. (60) have shown that chronic hypoxia differently regulates the generation of ROS in human pulmonary and coronary artery smooth muscle cells, with PASMC exhibiting an increase in ROS, whereas CASMC is showing a decrease. As one of the downstream effectors of ROS, ion channels including ROCC and SOCC are highly sensitive to the cellular redox status (16, 37); hence, chronic hypoxia may divergently regulate SOCC/ROCC by affecting intracellular ROS generation, which leads to diverse Ca2+ and contractile responses in pulmonary and coronary artery smooth muscles. Mitochondrial-derived ROS may also contribute to the different responses in these two types of vascular smooth muscle cells (CASMC vs. PASMC). Mitochondria in PASMC exhibit lower respiratory rates and higher rates of ROS and H2O2 production compared with the mitochondria in smooth muscle cells of systemic arteries (31). Accordingly, a recent study shows that a specific subunit 4 isoform of the mitochondrial complex IV, the cytochrome-c oxidase subunit 4 isoform 2 (Cox4i2), which is preferentially expressed in lungs, plays an important role in hypoxia-induced superoxide release and acute hypoxic pulmonary vasoconstriction (45). Mitochondria in PASMC also possess unique functional and metabolic properties that are different from systemic vascular smooth muscle cells (72).

In this study, we also determined and compared oxygen consumption profile for oxidative phosphorylation in CASMC and PASMC. No significant difference between CASMC and PASMC in terms of the mitochondrial respiration was observed; both basal respiration and the oxygen consumed for ATP production were comparable between CASMC and PASMC under resting conditions. The glycolysis, however, was higher in PASMC than in CASMC, suggesting that differences in metabolic profiles exist between PASMC and CASMC. Accumulating evidence suggests that mitochondria in PASMC appear structurally and functionally distinct from those in systemic arteries (12, 31). Michelakis et al. (31) showed that, at baseline, lung mitochondria are less active and have lower respiratory rates and higher rates of ROS and H2O2 production than kidney mitochondria. Recently, Zhu et al. (72) provided compelling evidence that transplantation of mitochondria derived from femoral artery smooth muscle cells inhibits acute hypoxia-induced pulmonary vasoconstriction, attenuates chronic hypoxia-mediated pulmonary vascular remodeling, and thus prevents the development of pulmonary hypertension and reverses the established pulmonary hypertension in rats exposed to chronic hypoxia. In the present study, however, we examined CASMC and PASMC under resting conditions. It is possible that, when the cells are exposed to hypoxia or stimulated by other cellular stressors, the mitochondrial function and/or oxygen consumption profile maybe different.

On the basis of data from our current study and others, it is plausible to speculate that glycolytic capacity might at least in part explain the distinct responses of PASMC and CASMC to hypoxia. It should be noted that our data do not prove a direct causal relationship between the mitochondrial diversity and differentially regulating protein expression (and function) of SOCC and ROCC. However, the results from this study are promising and provide clear clues for future in-depth study. Previous studies also implicate that hypoxia markedly increases mitochondrial ROS production in pulmonary, but not in systemic, vascular system. The increased mitochondrial ROS may result in Ca2+ entry through TRPC channels and increase [Ca2+]cyt in PASMC. In contrast, hypoxia has a negligible effect on mitochondrial ROS production to affect the expression and/or function of SOCC/ROCC in systemic vascular smooth muscle cells (56). These data direct us to hypothesize that mitochondrial ROS and glycolytic capacity may be responsible for differentially regulating protein expression (and function) of SOCC and ROCC in CASMC and PASMC, which contribute, at least in part, to the distinction of coronary and pulmonary arterial smooth muscle cells regarding their response to hypoxia.

One potential limitation of the present study is the use of cultured PASMC and CASMC, which may exhibit alterations compared with freshly isolated cells. Thus, caution should be used in drawing conclusions based on experiments using cultured cells as the study subject, as they may have different molecular features compared with freshly isolated cells. More studies using freshly isolated human tissue (when possible) are required to further prove and clarify the conclusions from the present study. Additionally, the previous study showed that modifying culture conditions could preserve the differentiated state of smooth muscle cells (22), which would be a better way to investigate cultured smooth muscle cells when freshly isolated smooth muscle cells are not suitable.

Furthermore, differential regulation of the IP3 and IP3 receptors (IP3R) through allosteric modifiers, for example, or Ca2+ feedback mechanisms, may cause the cells (e.g., CASMC and PASMC) to respond differently to the same agonist at the same concentration and duration. In CASMC and PASMC, we categorized the agonist-induced changes of [Ca2+]cyt into three patterns: pattern 1, a transient increase in [Ca2+]cyt; pattern 2, a transient increase in [Ca2+]cyt followed by a plateau or sustained increase in [Ca2+]cyt; and pattern 3, an oscillatory increase in [Ca2+]cyt. The kinetics and/or pattern of agonist-induced changes of [Ca2+]cyt depend largely on IP3 synthesis and IP3R activity, and IP3 interaction with IP3R. Therefore, differential regulation of IP3 and IP3R through endogenous intracellular regulators would be a central contributor to the three patterns of [Ca2+]cyt changes identified in CASMC and PASMC. More experiments on IP3 synthesis, IP3-IP3R interaction, and IP3R regulation in CASMC and PASMC are needed to define whether IP3 and its downstream signaling are the central arbiter of signaling properties involving the three patterns and of the differences between CASMC and PASMC.

An increase in [Ca2+]cyt due to Ca2+ entry through upregulated SOCC and ROCC may play an important pathogenic role in the development and progression of pulmonary vascular remodeling and vasoconstriction in pulmonary hypertension. The hypoxia-mediated upregulation of STIM1/2, Orai1/2, and TRPC6 in PASMC may reflect an intrinsic pathophysiological response unique to the pulmonary vasculature, which contributes to sustained pulmonary vasoconstriction and concentric pulmonary arterial wall thickening in patients and animals with hypoxia-induced pulmonary hypertension. Hypoxia-mediated upregulation of STIM1, Orai1/2, and TRPC6 is, however, not observed in CASMC so that hypoxia may result in coronary vasodilation via different mechanisms. Of note, a majority of previously reported studies are performed in animals or using animal cells; this study provides compelling evidence that hypoxia differentially regulates protein expression of ROCC and SOCC in coronary and pulmonary arterial smooth muscle cells, which may help improve our understanding of the molecular mechanisms involved in the functional distinction of the pulmonary and coronary vasculature.

GRANTS

This work was supported in part by the grants from the National Heart, Lung and Blood Institute of the National Institutes of Health (HL135807 and HL125208), the National Natural Science Foundation of China (Major International-Regional Joint Research Project, 81120108002, and Youth Project, 81503062), and China Postdoctoral Science Foundation (2017T100761).

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the author(s).

AUTHOR CONTRIBUTIONS

X.H., S.S., R.J.A., S.M.B., A.M., W.G.W., W.-J.Z., and J.X.-J.Y. conceived and designed research; X.H., S.S., R.J.A., and S.M.B. performed experiments; X.H., S.S., R.J.A., A.B., S.M.B., A.M., W.G.W., W.-J.Z., and J.X.-J.Y. analyzed data; X.H., S.S., R.J.A., A.B., S.M.B., A.M., W.G.W., W.-J.Z., and J.X.-J.Y. interpreted results of experiments; X.H., S.S., R.J.A., A.M., W.-J.Z., and J.X.-J.Y. prepared figures; X.H., W.-J.Z., and J.X.-J.Y. drafted manuscript; X.H., S.S., R.J.A., A.B., S.M.B., A.M., W.G.W., W.-J.Z., and J.X.-J.Y. edited and revised manuscript; X.H., S.S., R.J.A., A.B., S.M.B., A.M., W.G.W., W.-J.Z., and J.X.-J.Y. approved final version of manuscript.

REFERENCES

  • 1.Adesina SE, Kang BY, Bijli KM, Ma J, Cheng J, Murphy TC, Michael Hart C, Sutliff RL. Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension. Free Radic Biol Med 87: 36–47, 2015. doi: 10.1016/j.freeradbiomed.2015.05.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ahmad A, Ahmad S, Malcolm KC, Miller SM, Hendry-Hofer T, Schaack JB, White CW. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α. Am J Respir Cell Mol Biol 49: 78–85, 2013. doi: 10.1165/rcmb.2012-0107OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Aytes A, Molleví DG, Martinez-Iniesta M, Nadal M, Vidal A, Morales A, Salazar R, Capellà G, Villanueva A. Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype. Mol Carcinog 51: 746–753, 2012. doi: 10.1002/mc.20843. [DOI] [PubMed] [Google Scholar]
  • 4.Ball MK, Waypa GB, Mungai PT, Nielsen JM, Czech L, Dudley VJ, Beussink L, Dettman RW, Berkelhamer SK, Steinhorn RH, Shah SJ, Schumacker PT. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am J Respir Crit Care Med 189: 314–324, 2014. doi: 10.1164/rccm.201302-0302OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Beech DJ, Xu SZ, McHugh D, Flemming R. TRPC1 store-operated cationic channel subunit. Cell Calcium 33: 433–440, 2003. doi: 10.1016/S0143-4160(03)00054-X. [DOI] [PubMed] [Google Scholar]
  • 6.Berna-Erro A, Jardin I, Salido GM, Rosado JA. Role of STIM2 in cell function and physiopathology. J Physiol 595: 3111–3128, 2017. doi: 10.1113/JP273889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Boyer L, Chaar V, Pelle G, Maitre B, Chouaid C, Covali-Noroc A, Zerah F, Bucherer C, Lacombe C, Housset B, Dubois-Randé JL, Boczkowski J, Adnot S. Effects of polycythemia on systemic endothelial function in chronic hypoxic lung disease. J Appl Physiol (1985) 110: 1196–1203, 2011. doi: 10.1152/japplphysiol.01204.2010. [DOI] [PubMed] [Google Scholar]
  • 8.Brandman O, Liou J, Park WS, Meyer T. STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 131: 1327–1339, 2007. doi: 10.1016/j.cell.2007.11.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chen J, Sysol JR, Singla S, Zhao S, Yamamura A, Valdez-Jasso D, Abbasi T, Shioura KM, Sahni S, Reddy V, Sridhar A, Gao H, Torres J, Camp SM, Tang H, Ye SQ, Comhair S, Dweik R, Hassoun P, Yuan JX, Garcia JGN, Machado RF. Nicotinamide phosphoribosyltransferase promotes pulmonary vascular remodeling and is a therapeutic target in pulmonary arterial hypertension. Circulation 135: 1532–1546, 2017. doi: 10.1161/CIRCULATIONAHA.116.024557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chen TX, Xu XY, Zhao Z, Zhao FY, Gao YM, Yan XH, Wan Y. Hydrogen peroxide is a critical regulator of the hypoxia-induced alterations of store-operated Ca2+entry into rat pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 312: L477–L487, 2017. doi: 10.1152/ajplung.00138.2016. [DOI] [PubMed] [Google Scholar]
  • 11.Fernandez RA, Wan J, Song S, Smith KA, Gu Y, Tauseef M, Tang H, Makino A, Mehta D, Yuan JX. Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype. Am J Physiol Cell Physiol 308: C581–C593, 2015. doi: 10.1152/ajpcell.00202.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Firth AL, Gordienko DV, Yuill KH, Smirnov SV. Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation. Am J Physiol Lung Cell Mol Physiol 296: L347–L360, 2009. doi: 10.1152/ajplung.90341.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fuchs B, Rupp M, Ghofrani HA, Schermuly RT, Seeger W, Grimminger F, Gudermann T, Dietrich A, Weissmann N. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6. Respir Res 12: 20, 2011. doi: 10.1186/1465-9921-12-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Guo RW, Yang LX, Li MQ, Pan XH, Liu B, Deng YL. Stim1- and Orai1-mediated store-operated calcium entry is critical for angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res 93: 360–370, 2012. doi: 10.1093/cvr/cvr307. [DOI] [PubMed] [Google Scholar]
  • 15.Gupte SA, Wolin MS. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid Redox Signal 10: 1137–1152, 2008. doi: 10.1089/ars.2007.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Henke N, Albrecht P, Bouchachia I, Ryazantseva M, Knoll K, Lewerenz J, Kaznacheyeva E, Maher P, Methner A. The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death Dis 4: e470, 2013. doi: 10.1038/cddis.2012.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hussain A, Suleiman MS, George SJ, Loubani M, Morice A. Hypoxic pulmonary vasoconstriction in humans: tale or myth. Open Cardiovasc Med J 11: 1–13, 2017. doi: 10.2174/1874192401711010001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Inayama M, Suzuki Y, Yamada S, Kurita T, Yamamura H, Ohya S, Giles WR, Imaizumi Y. Orai1-Orai2 complex is involved in store-operated calcium entry in chondrocyte cell lines. Cell Calcium 57: 337–347, 2015. doi: 10.1016/j.ceca.2015.02.005. [DOI] [PubMed] [Google Scholar]
  • 19.Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, Ito Y. Transient receptor potential channels in cardiovascular function and disease. Circ Res 99: 119–131, 2006. doi: 10.1161/01.RES.0000233356.10630.8a. [DOI] [PubMed] [Google Scholar]
  • 20.Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, Mori Y. The transient receptor potential protein homologue TRP6 is the essential component of vascular α1-adrenoceptor-activated Ca2+-permeable cation channel. Circ Res 88: 325–332, 2001. doi: 10.1161/01.RES.88.3.325. [DOI] [PubMed] [Google Scholar]
  • 21.Itsuki K, Imai Y, Hase H, Okamura Y, Inoue R, Mori MX. PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. J Gen Physiol 143: 183–201, 2014. doi: 10.1085/jgp.201311033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Jarrousse C, Lods N, Michel F, Bali JP, Magous R. Cultured gastrointestinal smooth muscle cells: cell response to contractile agonists depends on their phenotypic state. Cell Tissue Res 316: 221–232, 2004. doi: 10.1007/s00441-004-0859-9. [DOI] [PubMed] [Google Scholar]
  • 23.Jiao HX, Mu YP, Gui LX, Yan FR, Lin DC, Sham JS, Lin MJ. Increase in caveolae and caveolin-1 expression modulates agonist-induced contraction and store- and receptor-operated Ca2+ entry in pulmonary arteries of pulmonary hypertensive rats. Vascul Pharmacol 84: 55–66, 2016. doi: 10.1016/j.vph.2016.06.004. [DOI] [PubMed] [Google Scholar]
  • 24.Ju M, Shi J, Saleh SN, Albert AP, Large WA. Ins(1,4,5)P3 interacts with PIP2 to regulate activation of TRPC6/C7 channels by diacylglycerol in native vascular myocytes. J Physiol 588: 1419–1433, 2010. doi: 10.1113/jphysiol.2009.185256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Jung S, Strotmann R, Schultz G, Plant TD. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells. Am J Physiol Cell Physiol 282: C347–C359, 2002. doi: 10.1152/ajpcell.00283.2001. [DOI] [PubMed] [Google Scholar]
  • 26.Jürgensen JS, Rosenberger C, Wiesener MS, Warnecke C, Hörstrup JH, Gräfe M, Philipp S, Griethe W, Maxwell PH, Frei U, Bachmann S, Willenbrock R, Eckardt KU. Persistent induction of HIF-1α and -2α in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J 18: 1415–1417, 2004. doi: 10.1096/fj.04-1605fje. [DOI] [PubMed] [Google Scholar]
  • 27.Kim EY, Alvarez-Baron CP, Dryer SE. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes. Mol Pharmacol 75: 466–477, 2009. doi: 10.1124/mol.108.051912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kuhr FK, Smith KA, Song MY, Levitan I, Yuan JX. New mechanisms of pulmonary arterial hypertension: role of Ca2+ signaling. Am J Physiol Heart Circ Physiol 302: H1546–H1562, 2012. doi: 10.1152/ajpheart.00944.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lin MJ, Leung GP, Zhang WM, Yang XR, Yip KP, Tse CM, Sham JS. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 95: 496–505, 2004. doi: 10.1161/01.RES.0000138952.16382.ad. [DOI] [PubMed] [Google Scholar]
  • 30.Makino A, Firth AL, Yuan JX. Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling. Compr Physiol 1: 1555–1602, 2011. doi: 10.1002/cphy.c100023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Michelakis ED, Hampl V, Nsair A, Wu X, Harry G, Haromy A, Gurtu R, Archer SL. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 90: 1307–1315, 2002. doi: 10.1161/01.RES.0000024689.07590.C2. [DOI] [PubMed] [Google Scholar]
  • 32.Moradkhan R, Spitnale B, McQuillan P, Hogeman C, Gray KS, Leuenberger UA. Hypoxia-induced vasodilation and effects of regional phentolamine in awake patients with sleep apnea. J Appl Physiol (1985) 108: 1234–1240, 2010. doi: 10.1152/japplphysiol.90855.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54, Suppl: S20–S31, 2009. doi: 10.1016/j.jacc.2009.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Motiani RK, Hyzinski-García MC, Zhang X, Henkel MM, Abdullaev IF, Kuo YH, Matrougui K, Mongin AA, Trebak M. STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion. Pflugers Arch 465: 1249–1260, 2013. doi: 10.1007/s00424-013-1254-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nakayama H, Wilkin BJ, Bodi I, Molkentin JD. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 20: 1660–1670, 2006. doi: 10.1096/fj.05-5560com. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ng LC, Ramduny D, Airey JA, Singer CA, Keller PS, Shen XM, Tian H, Valencik M, Hume JR. Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 299: C1079–C1090, 2010. doi: 10.1152/ajpcell.00548.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nunes P, Demaurex N. Redox regulation of store-operated Ca2+ entry. Antioxid Redox Signal 21: 915–932, 2014. doi: 10.1089/ars.2013.5615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ong HL, de Souza LB, Zheng C, Cheng KT, Liu X, Goldsmith CM, Feske S, Ambudkar IS. STIM2 enhances receptor-stimulated Ca2+ signaling by promoting recruitment of STIM1 to the endoplasmic reticulum-plasma membrane junctions. Sci Signal 8: ra3, 2015. doi: 10.1126/scisignal.2005748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Peng G, Li S, Hong W, Hu J, Jiang Y, Hu G, Zou Y, Zhou Y, Xu J, Ran P. Chronic hypoxia increases intracellular Ca2+ concentration via enhanced Ca2+ entry through receptor-operated Ca2+ channels in pulmonary venous smooth muscle cells. Circ J 79: 2058–2068, 2015. doi: 10.1253/circj.CJ-15-0067. [DOI] [PubMed] [Google Scholar]
  • 40.Platoshyn O, Yu Y, Golovina VA, McDaniel SS, Krick S, Li L, Wang JY, Rubin LJ, Yuan JX. Chronic hypoxia decreases KV channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol 280: L801–L812, 2001. doi: 10.1152/ajplung.2001.280.4.L801. [DOI] [PubMed] [Google Scholar]
  • 41.Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230–233, 2006. doi: 10.1038/nature05122. [DOI] [PubMed] [Google Scholar]
  • 42.Rathore R, Zheng YM, Niu CF, Liu QH, Korde A, Ho YS, Wang YX. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCɛ signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med 45: 1223–1231, 2008. doi: 10.1016/j.freeradbiomed.2008.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Shimoda LA, Undem C. Interactions between calcium and reactive oxygen species in pulmonary arterial smooth muscle responses to hypoxia. Respir Physiol Neurobiol 174: 221–229, 2010. doi: 10.1016/j.resp.2010.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Smith KA, Voiriot G, Tang H, Fraidenburg DR, Song S, Yamamura H, Yamamura A, Guo Q, Wan J, Pohl NM, Tauseef M, Bodmer R, Ocorr K, Thistlethwaite PA, Haddad GG, Powell FL, Makino A, Mehta D, Yuan JX. Notch activation of Ca2+ signaling in the development of hypoxic pulmonary vasoconstriction and pulmonary hypertension. Am J Respir Cell Mol Biol 53: 355–367, 2015. doi: 10.1165/rcmb.2014-0235OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sommer N, Hüttemann M, Pak O, Scheibe S, Knoepp F, Sinkler C, Malczyk M, Gierhardt M, Esfandiary A, Kraut S, Jonas F, Veith C, Aras S, Sydykov A, Alebrahimdehkordi N, Giehl K, Hecker M, Brandes RP, Seeger W, Grimminger F, Ghofrani HA, Schermuly RT, Grossman LI, Weissmann N. Mitochondrial complex IV subunit 4 isoform 2 is essential for acute pulmonary oxygen sensing. Circ Res 121: 424–438, 2017. doi: 10.1161/CIRCRESAHA.116.310482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Song MY, Makino A, Yuan JX. STIM2 contributes to enhanced store-operated Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Pulm Circ 1: 84–94, 2011. doi: 10.4103/2045-8932.78106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Song S, Ayon RJ, Yamamura A, Yamamura H, Dash S, Babicheva A, Tang H, Sun X, Cordery AG, Khalpey Z, Black SM, Desai AA, Rischard F, McDermott KM, Garcia JG, Makino A, Yuan JX. Capsaicin-induced Ca2+signaling is enhanced via upregulated TRPV1 channels in pulmonary artery smooth muscle cells from patients with idiopathic PAH. Am J Physiol Lung Cell Mol Physiol 312: L309–L325, 2017. doi: 10.1152/ajplung.00357.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Stanisz H, Saul S, Müller CS, Kappl R, Niemeyer BA, Vogt T, Hoth M, Roesch A, Bogeski I. Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry. Pigment Cell Melanoma Res 27: 442–453, 2014. doi: 10.1111/pcmr.12222. [DOI] [PubMed] [Google Scholar]
  • 49.Strielkov I, Pak O, Sommer N, Weissmann N. Recent advances in oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction. J Appl Physiol (1985) 123: 1647–1656, 2017. doi: 10.1152/japplphysiol.00103.2017. [DOI] [PubMed] [Google Scholar]
  • 50.Tan W, Madhavan K, Hunter KS, Park D, Stenmark KR. Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). Pulm Circ 4: 560–580, 2014. doi: 10.1086/677370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tang C, To WK, Meng F, Wang Y, Gu Y. A role for receptor-operated Ca2+ entry in human pulmonary artery smooth muscle cells in response to hypoxia. Physiol Res 59: 909–918, 2010. [DOI] [PubMed] [Google Scholar]
  • 52.Tang H, Yamamura A, Yamamura H, Song S, Fraidenburg DR, Chen J, Gu Y, Pohl NM, Zhou T, Jiménez-Pérez L, Ayon RJ, Desai AA, Goltzman D, Rischard F, Khalpey Z, Black SM, Garcia JG, Makino A, Yuan JX. Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 310: L846–L859, 2016. doi: 10.1152/ajplung.00050.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wan J, Yamamura A, Zimnicka AM, Voiriot G, Smith KA, Tang H, Ayon RJ, Choudhury MS, Ko EA, Wang J, Wang C, Makino A, Yuan JX. Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2. Am J Physiol Lung Cell Mol Physiol 305: L154–L164, 2013. doi: 10.1152/ajplung.00313.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wang J, Shimoda LA, Weigand L, Wang W, Sun D, Sylvester JT. Acute hypoxia increases intracellular [Ca2+] in pulmonary arterial smooth muscle by enhancing capacitative Ca2+ entry. Am J Physiol Lung Cell Mol Physiol 288: L1059–L1069, 2005. doi: 10.1152/ajplung.00448.2004. [DOI] [PubMed] [Google Scholar]
  • 55.Wang J, Weigand L, Lu W, Sylvester JT, Semenza GL, Shimoda LA. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells. Circ Res 98: 1528–1537, 2006. doi: 10.1161/01.RES.0000227551.68124.98. [DOI] [PubMed] [Google Scholar]
  • 56.Wang YX, Zheng YM. Role of ROS signaling in differential hypoxic Ca2+ and contractile responses in pulmonary and systemic vascular smooth muscle cells. Respir Physiol Neurobiol 174: 192–200, 2010. doi: 10.1016/j.resp.2010.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, Schumacker PT. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ Res 106: 526–535, 2010. doi: 10.1161/CIRCRESAHA.109.206334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, Olschewski A, Storch U, Mederos y Schnitzler M, Ghofrani HA, Schermuly RT, Pinkenburg O, Seeger W, Grimminger F, Gudermann T. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci USA 103: 19093–19098, 2006. doi: 10.1073/pnas.0606728103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Wu K, Zhang Q, Wu X, Lu W, Tang H, Liang Z, Gu Y, Song S, Ayon RJ, Wang Z, McDermott KM, Balistrieri A, Wang C, Black SM, Garcia JGN, Makino A, Yuan JX, Wang J. Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension. Br J Pharmacol 174: 4155–4172, 2017. doi: 10.1111/bph.13990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Wu W, Platoshyn O, Firth AL, Yuan JX. Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 293: L952–L959, 2007. doi: 10.1152/ajplung.00203.2007. [DOI] [PubMed] [Google Scholar]
  • 61.Xia Y, Yang XR, Fu Z, Paudel O, Abramowitz J, Birnbaumer L, Sham JS. Classical transient receptor potential 1 and 6 contribute to hypoxic pulmonary hypertension through differential regulation of pulmonary vascular functions. Hypertension 63: 173–180, 2014. doi: 10.1161/HYPERTENSIONAHA.113.01902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Xu Y, Zhang S, Niu H, Ye Y, Hu F, Chen S, Li X, Luo X, Jiang S, Liu Y, Chen Y, Li J, Xiang R, Li N. STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer. Sci Rep 5: 11754, 2015. doi: 10.1038/srep11754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Yamamura A, Guo Q, Yamamura H, Zimnicka AM, Pohl NM, Smith KA, Fernandez RA, Zeifman A, Makino A, Dong H, Yuan JX. Enhanced Ca2+-sensing receptor function in idiopathic pulmonary arterial hypertension. Circ Res 111: 469–481, 2012. doi: 10.1161/CIRCRESAHA.112.266361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Yamamura A, Yamamura H, Guo Q, Zimnicka AM, Wan J, Ko EA, Smith KA, Pohl NM, Song S, Zeifman A, Makino A, Yuan JX. Dihydropyridine Ca2+ channel blockers increase cytosolic Ca2+ by activating Ca2+-sensing receptors in pulmonary arterial smooth muscle cells. Circ Res 112: 640–650, 2013. doi: 10.1161/CIRCRESAHA.113.300897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Yamamura H, Yamamura A, Ko EA, Pohl NM, Smith KA, Zeifman A, Powell FL, Thistlethwaite PA, Yuan JX. Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca2+ entry in human pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 306: C871–C878, 2014. doi: 10.1152/ajpcell.00221.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Yu L, Hales CA. Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats. Respir Res 12: 21, 2011. doi: 10.1186/1465-9921-12-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Zhang S, Dong H, Rubin LJ, Yuan JX. Upregulation of Na+/Ca2+ exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol 292: C2297–C2305, 2007. doi: 10.1152/ajpcell.00383.2006. [DOI] [PubMed] [Google Scholar]
  • 68.Zhang S, Yuan JX, Barrett KE, Dong H. Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 288: C245–C252, 2005. doi: 10.1152/ajpcell.00411.2004. [DOI] [PubMed] [Google Scholar]
  • 69.Zhang X, Zhang W, González-Cobos JC, Jardin I, Romanin C, Matrougui K, Trebak M. Complex role of STIM1 in the activation of store-independent Orai1/3 channels. J Gen Physiol 143: 345–359, 2014. doi: 10.1085/jgp.201311084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Zheng L, Stathopulos PB, Li GY, Ikura M. Biophysical characterization of the EF-hand and SAM domain containing Ca2+ sensory region of STIM1 and STIM2. Biochem Biophys Res Commun 369: 240–246, 2008. doi: 10.1016/j.bbrc.2007.12.129. [DOI] [PubMed] [Google Scholar]
  • 71.Zheng YM, Park SW, Stokes L, Tang Q, Xiao JH, Wang YX. Distinct activity of BK channel β1-subunit in cerebral and pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 304: C780–C789, 2013. doi: 10.1152/ajpcell.00006.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Zhu L, Zhang J, Zhou J, Lu Y, Huang S, Xiao R, Yu X, Zeng X, Liu B, Liu F, Sun M, Dai M, Hao Q, Li J, Wang T, Li T, Hu Q. Mitochondrial transplantation attenuates hypoxic pulmonary hypertension. Oncotarget 7: 48925–48940, 2016. doi: 10.18632/oncotarget.10596. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Physiology - Cell Physiology are provided here courtesy of American Physiological Society

RESOURCES